Efficacy of potassium polycitrate on renal stone and microlithiasis predisposed by metabolic disorders
- PMID: 29201321
- PMCID: PMC5686309
- DOI: 10.22088/cjim.8.4.296
Efficacy of potassium polycitrate on renal stone and microlithiasis predisposed by metabolic disorders
Abstract
Background: According to high prevalence of renal stone in children, we evaluated the efficacy of treatment with potassium citrate and its correlation with metabolic disorders in children less than two years of age with renal stone and microlithiasis.
Methods: In this cross- sectionaly study, 100 patients (less than 2 years old) with renal stone or microlitiasis were evaluated for metabolic disorders. They were treated with potassium citrate and followed-up by ultrasonography every 3 months. Then response to treatment was evaluated according to the fresence metabolic disorders (A p-alue<0.05 was significant).
Results: According to this study, hyperuricosuria and hypercalciuria were the two major metabolic disorders (40-33%). Seventy three patients had complete response, and also there as not a significant difference (p<0.05) in the efficacy of treatment due to types of metabolic disorders. There was significant difference between relative response to treatment in children who had metabolic disorders and patient without any metabolic disorders.
Conclusion: Based on our results the use of potassium citrate in all children less than 2 years with renal stone or microlithiasis especially those with metabolic disorders, are recommended.
Keywords: Children less than 2 Years.; Hypercalciuria; Hyperuricosuria; Metabolic disorders; Potassium polycitrate; Renal stone.
Conflict of interest statement
There was no conflict of interest.
Figures
Similar articles
-
Effect of potassium citrate therapy on stone recurrence and regrowth after extracorporeal shockwave lithotripsy in children.J Endourol. 2006 Nov;20(11):875-9. doi: 10.1089/end.2006.20.875. J Endourol. 2006. PMID: 17144854
-
[Sodium excretion in children with lithogenic disorders].Srp Arh Celok Lek. 1998 Sep-Oct;126(9-10):321-6. Srp Arh Celok Lek. 1998. PMID: 9863402 Serbian.
-
Potassium citrate vs. hydrochlorothiazide to reduce urinary calcium excretion in calcium oxalate stone patients with hypercalciuria: a prospective randomized study.Int Urol Nephrol. 2021 Sep;53(9):1791-1796. doi: 10.1007/s11255-021-02879-7. Epub 2021 Apr 26. Int Urol Nephrol. 2021. PMID: 33904027 Clinical Trial.
-
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105. Arch Ital Urol Androl. 2015. PMID: 26150027 Review.
-
[Therapeutic use of potassium citrate].Przegl Lek. 2001;58(2):82-6. Przegl Lek. 2001. PMID: 11475849 Review. Polish.
Cited by
-
Effect of Prunus cerasus (Sour Cherry) on Nephrolithiasis in Children: The First Noninferiority Two-Arm Randomized Clinical Trial.Urol Res Pract. 2024 Mar;50(2):134-138. doi: 10.5152/tud.2024.23206. Urol Res Pract. 2024. PMID: 39128111 Free PMC article.
-
Glomerular filtration rate determination by creatinine and cystatin-C in patients with acute pyelonephritis.Caspian J Intern Med. 2018 Summer;9(3):290-295. doi: 10.22088/cjim.9.3.290. Caspian J Intern Med. 2018. PMID: 30197775 Free PMC article.
References
-
- Guan N, Fan Q, Ding J, et al. Melamine-contaminated powered formula and urolithiasis in young children. N Engl J Med. 2009;360:1067–74. - PubMed
-
- Kobayashi T, Okada A, Fujii Y, et al. The mechanism of renal stone formation and renal failure induced by administration of melamine and cyanuric acid. Urol Res. 2010;38:117–25. - PubMed
-
- VanDervoort K, Wiesen J, Frank R, et al. Urolithiasis in pediatric patients: a single center study of incidence, clinicalpresentation and outcome. J Urol. 2007;177:2300–5. - PubMed
-
- Vant Hoff WG. Aetiological factors in paediatric urolithiasis. Nephron Clin Pract. 2004;98:45–8. - PubMed
LinkOut - more resources
Full Text Sources